| | | | | | | | | | |
| | |
 | Issue Date FY: 2021 ( Subtotal = $12,870,651 ) (Continued on the next page) |
| | 2021 | 2021 | R01DK114187 | Catecholamine Neurons and Metabolic Controls | 000 | 4 | NIH | 2/2/2021 | 041485301 | $451,986 |
| | 2021 | 2021 | P60AA026112 | Native Center for Alcohol Research and Education | 001 | 4 | NIH | 12/1/2020 | 041485301 | $1,277,355 |
| | 2021 | 2021 | R01ES032558 | Mechanisms of microcystin-induced hepatocellular carcinoma in nonalcoholic steatohepatitis | 000 | 1 | NIH | 1/18/2021 | 041485301 | $455,810 |
| | 2021 | 2021 | R21CA256382 | Near-IR Ratiometric Fluorescence Probes for Assessing Cargo Delivery to Prostate Tumors | 000 | 1 | NIH | 1/14/2021 | 041485301 | $224,845 |
| | 2021 | 2021 | R01AA027209 | Integration of Motivational Interviewing and Behavioral Economics Theories to Enhance Measurement of Client Language as a Mechanism of Behavior Change | 000 | 2 | NIH | 2/22/2021 | 041485301 | $396,036 |
| | 2021 | 2021 | R01MH122844 | Endocannabinoid Modulation of the Habenular Stress Response | 000 | 1 | NIH | 11/19/2020 | 041485301 | $382,500 |
| | 2021 | 2021 | R37CA233658 | MAOA and AR Reciprocal Crosstalk in Prostate Cancer | 000 | 3 | NIH | 12/18/2020 | 041485301 | $332,488 |
| | 2021 | 2021 | R37CA233658 | MAOA and AR Reciprocal Crosstalk in Prostate Cancer | 001 | 3 | NIH | 1/25/2021 | 041485301 | $17,500 |
| | 2021 | 2021 | R01AI141712 | Eliminating human rabies: impact of enhanced vaccination coverage | 000 | 3 | NIH | 10/16/2020 | 041485301 | $562,971 |
| | 2021 | 2021 | R21AI155756 | Mechanistic and Functional Analysis of a Putative Regulatory Factor in the Lyme Disease Spirochete | 000 | 1 | NIH | 12/9/2020 | 041485301 | $191,250 |
| | 2021 | 2021 | D43TW011519 | Zoonotic and Emerging Infectious Diseases Training Program | 000 | 2 | NIH | 1/12/2021 | 041485301 | $135,883 |
| | 2021 | 2021 | D43TW011519 | Zoonotic and Emerging Infectious Diseases Training Program | 000 | 2 | NIH | 1/12/2021 | 041485301 | $100,000 |
| | 2021 | 2021 | R01AI129992 | Effectors of Brucella intracellular replication | 000 | 5 | NIH | 12/14/2020 | 041485301 | $371,887 |
| | 2021 | 2021 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $150,000 |
| | 2021 | 2021 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $1,060,000 |
| | 2021 | 2021 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $450,000 |
| | 2021 | 2021 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $26,452 |
| | 2021 | 2021 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $450,000 |
| | 2021 | 2021 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $1,325,000 |
| | 2021 | 2021 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $752,008 |
| | 2021 | 2021 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $470,000 |
| | 2021 | 2021 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $171,000 |
| | 2021 | 2021 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $400,000 |
| | 2021 | 2021 | R01HL151472 | Cell cycle proteins as key regulators of cardiac chemosensitivity | 000 | 1 | NIH | 2/16/2021 | 041485301 | $446,769 |
| | 2021 | 2021 | R21AA028106 | Ubiquitin-system manipulations to probe and mitigate ethanol damage in neurons | 000 | 1 | NIH | 2/22/2021 | 041485301 | $178,767 |
| | 2021 | 2021 | R01MD016526 | Marshallese: Alternate Surveillance for COVID-19 in a Unique Population | 000 | 1 | NIH | 12/21/2020 | 041485301 | $722,487 |
| | 2021 | 2021 | R01GM140129 | Tractable Tandem Ion Mobility Technology using Structures for Lossless Ion Manipulations and Photodissociation | 000 | 1 | NIH | 12/28/2020 | 041485301 | $285,876 |
| | 2021 | 2021 | R01AR078241 | Bio-tribo-corrosion resistant 3D Printed Composites for Load-bearing Implants | 000 | 1 | NIH | 1/22/2021 | 041485301 | $330,030 |
| | 2021 | 2021 | R21CA248734 | Two-Dimensional Multi-Stage Isotachophoretic Technology for Multiplex Analysis of Cancer Exosomes and Proteins Marker Panel | 000 | 1 | NIH | 12/25/2020 | 041485301 | $207,968 |
| | 2021 | 2021 | K01DA051780 | Effective Caregiving for Neonatal Abstinence Syndrome: Development of an Instructional Mobile Technology Platform for High-Risk Pregnant Women | 000 | 1 | NIH | 2/18/2021 | 041485301 | $17,453 |
| | 2021 | 2021 | R21AI151412 | Anaplasma phagocytophilum modulates the type IV secretion system pilus to achieve tick transmission | 000 | 2 | NIH | 1/25/2021 | 041485301 | $191,250 |
| | 2021 | 2021 | R01GM133883 | Induction of Cell Death by Dietary Fatty Acids | 000 | 2 | NIH | 1/27/2021 | 041485301 | $300,016 |
| | 2021 | 2021 | R01HD097087 | The actions of steroid hormones on oviduct function | 000 | 3 | NIH | 2/17/2021 | 041485301 | $355,576 |
| | 2021 | 2021 | P60AA026112 | Native Center for Alcohol Research and Education | 002 | 4 | NIH | 2/23/2021 | 041485301 | $141,930 |
| | 2021 | 2020 | NU2GGH001717 | GH15-1632, Kenya: PREVENTING ZOONOTIC DISEASES (GHSA STRATEGY #3) IN KENYA | 06 | 3 | CDC | 10/15/2020 | 041485301 | $0 |
| | 2021 | 2020 | U01GH002241 | COVID-19 Supplement. An Integrated Surveillance Platform for Infectious Diseases and Their Burden on Antibiotic Resistance | 01 | 3 | CDC | 11/25/2020 | 041485301 | $0 |
| | 2021 | 2020 | U01GH002241 | COVID-19 Supplement. An Integrated Surveillance Platform for Infectious Diseases and Their Burden on Antibiotic Resistance | 01 | 3 | CDC | 11/25/2020 | 041485301 | $0 |
| | 2021 | 2020 | U01GH002241 | COVID-19 Supplement. An Integrated Surveillance Platform for Infectious Diseases and Their Burden on Antibiotic Resistance | 01 | 3 | CDC | 11/25/2020 | 041485301 | $0 |
| | 2021 | 2020 | U01GH002241 | COVID-19 Supplement. An Integrated Surveillance Platform for Infectious Diseases and Their Burden on Antibiotic Resistance | 06 | 2 | CDC | 12/23/2020 | 041485301 | $0 |
| | 2021 | 2020 | U01GH002241 | COVID-19 Supplement. An Integrated Surveillance Platform for Infectious Diseases and Their Burden on Antibiotic Resistance | 02 | 3 | CDC | 1/15/2021 | 041485301 | $0 |
| | 2021 | 2020 | U01GH002241 | COVID-19 Supplement. An Integrated Surveillance Platform for Infectious Diseases and Their Burden on Antibiotic Resistance | 02 | 3 | CDC | 1/15/2021 | 041485301 | $0 |
| | 2021 | 2020 | U01GH002241 | COVID-19 Supplement. An Integrated Surveillance Platform for Infectious Diseases and Their Burden on Antibiotic Resistance | 02 | 3 | CDC | 1/15/2021 | 041485301 | $0 |
| | 2021 | 2020 | 90ARCP0001 | Collaborative on Health Reform and Independent Living Fellowship (CHRIL-F) | 01 | 4 | ACL | 2/3/2021 | 041485301 | $0 |
| | 2021 | 2020 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $0 |
| | 2021 | 2020 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $0 |
| | 2021 | 2020 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $0 |
| | 2021 | 2020 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 02 | 1 | CDC | 2/23/2021 | 041485301 | $0 |
| | 2021 | 2020 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 01 | 1 | CDC | 12/7/2020 | 041485301 | $0 |
| | 2021 | 2020 | NU2HGH000031 | Enhancing Preparedness and Response to Communicable Diseases in Kenya | 01 | 1 | CDC | 12/7/2020 | 041485301 | $0 |
|
